RECIST: no longer the sharpest tool in the oncology clinical trials toolbox--reply to point

Cancer Res. 2012 Oct 15;72(20):5150. doi: 10.1158/0008-5472.CAN-12-1989. Epub 2012 Sep 4.

Authors

Antonio T Fojo¹, Anne Noonan

Affiliation

¹ NIH, NCI, Medicine Branch, Bethesda, MD 220892, USA. fojot@mail.nih.gov

PMID: 22952222
DOI: 10.1158/0008-5472.CAN-12-1989

No abstract available

MeSH terms

Clinical Trials as Topic*
Evidence-Based Medicine
Humans
Neoplasms / therapy*